A study by Atmaca, in 2020, showed that assessment of ESR1 mRNA by qPCR is a feasible method to examine ESR1 expression in NSCLC, and ESR1 expression determines the prognosis of metastatic NSCLC. The gene discussed is ESR1; the disease is non-small cell lung carcinoma.